Xuedong Wang1, Ailian Liu1, Jiazheng Wang2, Ke Jiang2, and Anliang Chen1
1The first affiliated hospital of dalian medical university, DaLian, China, 2Philips Healthcare, China, Beijing, China
Synopsis
T2
mapping is an effective sequence of MRI that enables quantitative assessment of
diseases. However, currently there are few trials to confirm its feasibility in
distinguishing pancreatic changes due to benign and malignant low biliary
obstruction. In this experiment, we used T2 mapping to quantify these changes,
and found that T2 mapping is feasible for evaluating the changes of pancreatic
parenchyma due to benign and malignant low biliary obstruction. And the value
of T2 mapping in malignant group is higher than that in benign group.
Introduction
T2 mapping plays
an important role in diagnosis of diseases[1] due to its
quantitative ability. So far, the application of T2 mapping has been applied to
heart, nerve, bone joints and so on, however, seldom work has been reported
about its application in pancreatic diseases. Therefore, this study aims to
explore the application of T2mapping quantitative imaging in pancreatic changes
after benign and malignant bile duct obstruction.Material and methods
Malignant group with 6
cases and benign group with 7 cases were enrolled in this retrospective study. The
study was performed on a 3.0T MR scanner (Ingenia 3.0T CX; Philips Healthcare,
Best, the Netherlands) with a 32-channel abdominal array coil.Scanning
sequences: axial T2-weighted imaging (T2WI),T2 mapping And
Diffusion-weighted imaging (DWI). Scanning parameters: T2WI: TR/TE=
4900/85ms, FOV=240x 240x 119mm3,
voxel size 0.7x0.7x4mm3,
scan time=2min48s;T2 mapping: TR/TE=1157/20ms, FOV=400 x319 x70mm3, voxel size 2.1 x2.62
x7mm3, scan time=1min58s;DWI: TR/TE= 3900/60ms, FOV=240x240x119 mm3, voxel size
3.0x3.0x4mm3, scan
time=1 min 46s. All data were transferred to the IntelliSpace Portal,
(Philips Healthcare). Two physicians with 3 years and 6 years of MRI diagnosis
experience were employed to drawregion of interest(ROI) in the uniform areas of
parenchymal signals in the head, body, and tail of the pancreas with dilated pancreatic ducts avoided.(Figure 1). The value of ROI drawn by
the senior physician was taken as statistical analysis,and averagevalue of ROI
for three times was taken as the follow-up statistical analysis. Intra-group
correlation coefficient (ICC) was used to test the consistency of the
measurement results of the two observers.The difference of parameters
between the two groupswere performed by Mann-Whitney U test.Results
The consistency of data measured by two observers was good
(ICC>0.75)( Table 1).T2 mapping value of pancreatic changes caused by
malignant low biliary tract obstruction was higher than that of benign group
with statistical difference (P<0.05)( Table 2). T2 mapping value were
90.065 as the differential diagnosis thresholds, the corresponding diagnostic
sensitivity and specificity were 83.3% and 100%, and the AUC value were 0.857(Figure2).Discussion and Conclusion
In this study we illustrate the feasibility of T2 mapping in evaluating
the parenchymal changes of the pancreascaused by benign and malignant low
biliary tract obstruction.. Results shows that T2 value in malignat groupis significantly
higher than that inthe benign group, which indicates that T2 mapping may be an
effective tool fordiagnosis ofsuch pancreatic diseases.Acknowledgements
no acknowledgements foundsReferences
[1]Hamlin
SA, Henry TS, Little BP, et al. Mapping the future of cardiac MR imaging:
case-based review of T1 and T2 mapping techniques. Radiograohics.
2014;34(6):1594-1611.